drugset / Trial / NCT06423872
A SAD Study of ZT002 Injection in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will comprise a randomized, parallel assignment, double blind, placebo controlled, single and multiple ascending dose, safety, tolerability and pharmacokinetic study of ZT002 in healthy participants.
Timeline
- Start
- 2023-06-19
- Primary completion
- 2023-10-20
- Completion
- 2023-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZT002 | Peptide | — | Subcutaneous |